Form 4 for INBX Inhibrx Biosciences, Inc.
Accepted 2024-06-04 00:00:00 ET · period of report 2024-05-31 · accession 0002007919-24-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2024-06-04 | 2024-05-31+ | INBX | Kayyem Jon Faiz | Dir | P - Purchase | $17.18 | +286.8K | 923.1K | +45% | +$4.93M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-03 | P | A | 80,738 | $17.90 | 1,003,798 | I By The Jon F. Kayyem and Paige Gates-Kayyem Family Trust | — | — | (F3) The shares were purchased in multiple transactions at prices ranging from $17.40 to $18.10, inclusive. The reported price reflects the weighted-average purchase price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. |
| 2 | Common | Common Stock | 2024-06-04 | P | A | 65,337 | $17.44 | 1,069,135 | I By The Jon F. Kayyem and Paige Gates-Kayyem Family Trust | — | — | (F4) The shares were purchased in multiple transactions at prices ranging from $17.01 to $18.00, inclusive. The reported price reflects the weighted-average purchase price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. |
| 3 | Common | Common Stock | 2024-06-04 | P | A | 23,726 | $18.24 | 1,092,861 | I By The Jon F. Kayyem and Paige Gates-Kayyem Family Trust | — | — | (F5) The shares were purchased in multiple transactions at prices ranging from $18.01 to $18.50, inclusive. The reported price reflects the weighted-average purchase price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. |
| 4 | Common | Common Stock | 2024-05-31 | P | A | 70,193 | $16.14 | 876,268 | I By The Jon F. Kayyem and Paige Gates-Kayyem Family Trust | — | — | (F1) The shares were purchased in multiple transactions at prices ranging from $15.75 to $16.25, inclusive. The reported price reflects the weighted-average purchase price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. |
| 5 | Common | Common Stock | 2024-06-03 | P | A | 46,792 | $16.61 | 923,060 | I By The Jon F. Kayyem and Paige Gates-Kayyem Family Trust | — | — | (F2) The shares were purchased in multiple transactions at prices ranging from $16.25 to $16.75, inclusive. The reported price reflects the weighted-average purchase price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. |